Elke A. Jarboe
No Rating Available
(Learn About Our Rating System)

Elke A. Jarboe, MD

Languages spoken: English

  • Dr. Jarboe is a staff pathologist at ARUP and an associate professor of pathology at the University of Utah School of Medicine. She received her MD from and completed her anatomic pathology residency training at the University of Colorado School of Medicine. Subsequently, she completed fellowships in women’s and perinatal pathology and cytopathology at Brigham and Women's Hospital in Boston. Dr. Jarboe is a member of several professional societies, including the United States and Canadian Academy of Pathology, American Association for Cancer Research, American Society for Clinical Pathology, and College of American Pathologists.

    Dr. Jarboe's primary subspecialty and research interest is in gynecologic pathology.

    Specialties

    • Pathology, Anatomical

    Board Certification

    National Board of Medical Examiners
    American Board of Pathology (Sub: Cytopathology)
    American Board of Pathology (Anatomic)

  • Dr. Jarboe is a staff pathologist at ARUP and an associate professor of pathology at the University of Utah School of Medicine. She received her MD from and completed her anatomic pathology residency training at the University of Colorado School of Medicine. Subsequently, she completed fellowships in women’s and perinatal pathology and cytopathology at Brigham and Women's Hospital in Boston. Dr. Jarboe is a member of several professional societies, including the United States and Canadian Academy of Pathology, American Association for Cancer Research, American Society for Clinical Pathology, and College of American Pathologists.

    Dr. Jarboe's primary subspecialty and research interest is in gynecologic pathology.

    Board Certification and Academic Information

    Academic Departments Pathology -Associate Professor (Clinical)
    Obstetrics & Gynecology -Adjunct Assistant Professor
    Academic Divisions Gynecological Oncology
    Board Certification
    National Board of Medical Examiners
    American Board of Pathology (Sub: Cytopathology)
    American Board of Pathology (Anatomic)

    Education history

    Undergraduate Microbiology - Colorado State University B.S.
    Graduate Training Microbiology - Colorado State University M.S.
    Professional Medical Medicine - University of Colorado School of Medicine M.D.
    Fellowship University of Colorado School of Medicine Post-Sophomore Fellow
    Internship Pathology - University of Colorado School of Medicine Intern
    Residency Pathology - University of Colorado School of Medicine Resident
    Fellowship Division of Women's and Perinatal Pathology - Brigham and Women's Hospital Fellow
    Fellowship Cytopathology - Brigham and Women's Hospital Fellow

    Selected Publications

    Journal Article

    1. Baniak N, Fadare O, Köbel M, DeCoteau J, Parkash V, Hecht JL, Hanley KZ, Gwin K, Zheng W, Quick CM, Jarboe EA, Liang SX, Kinloch (2019). Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies Are Uncommon. The American journal of surgical pathology, 43(4), 531-537. (Read full publication)
    2. Folkins AK, Jarboe EA, Saleemuddin A, Lee Y, Callahan MJ, Drapkin R, Garber JE, Muto MG, Tworoger S, Crum C (2008). A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. (cited over 300 times). Gynecologic oncology, 109(2), 168-73. (Read full publication)
    3. Fadare O, Roma AA, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Zheng W, Hecht JL, Parkash V, Wang X (2018). The significance of L1CAM expression in clear cell carcinoma of the endometrium. Histopathology, 72(3), 532-538. (Read full publication)
    4. Jarboe EA, Thompson LC, Heinz D, McGregor JA, Shroyer K (2004). Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma. Human pathology, 35(4), 396-402. (Read full publication)
    5. Jarboe EA, Folkins AK, Nucci MR, Kindelberger D, Drapkin R, Miron A, Lee Y, Crum C (2008). Serous Carcinogenesis in the Fallopian Tube (SCAT): A Descriptive Classification (cited over 300 times) (Journal cover image). International journal of gynecological pathology, 27(1), 1-9.
    6. Fadare O, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Rawish KR, Roma AA, Zheng W, Hecht JL, Parkash V, Osunkoya A (2018). Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases. International journal of gynecological pathology, 37(6), 525-535. (Read full publication)
    7. Dillon C, Rezvani M, McLean H, Adelman M, Dassel M, Jarboe E, Janát-Amsbury M, Payne (2019). A tissue preparation to characterize uterine fibroid tissue properties for thermal therapies. Medical physics, 46(8), 3344-3355. (Read full publication)
    8. Vahrenkamp JM, Szczotka K, Dodson MK, Jarboe EA, Soisson AP, Gertz (2019). FFPEcap-seq: a method for sequencing capped RNAs in formalin-fixed paraffin-embedded samples. (Journal impact factor 6.2). Genome research, 29(11), 1826-1835. (Read full publication)
    9. Taurin S, Yang CH, Reyes M, Cho S, Coombs DM, Jarboe EA, Werner TL, Peterson CM, Janát-Amsbury M (2018). Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model. International journal of gynecological cancer, 28(1), 152-160. (Read full publication)
    10. Vahrenkamp JM, Yang CH, Rodriguez AC, Almomen A, Berrett KC, Trujillo AN, Guillen KP, Welm BE, Jarboe EA, Janat-Amsbury MM, Gertz (2018). Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor α In Endometrial Cancer. (Journal impact factor 9.423). Cell reports, 22(11), 2995-3005. (Read full publication)
    11. Blanchard Z, Rush CM, Arnesen S, Vahrenkamp JM, Rodriguez AC, Jarboe EA, Brown C, Chang MEK, Flory MR, Mohammed H, Modzelewska K, Lum DH, Gertz (2023). Allele-Specific Gene Regulation, Phenotypes, and Therapeutic Vulnerabilities in Estrogen Receptor Alpha-Mutant Endometrial Cancer. Molecular cancer research, 21(10), 1023-1036. (Read full publication)
    12. Barnard ME, Meeks H, Jarboe EA, Albro J, Camp NJ, Doherty J (2023). Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: a population-based study. Journal of medical genetics, 60(2), 119-127. (Read full publication)
    13. Shen Z, Kang J, Shakya A, Tabaka M, Jarboe EA, Regev A, Tantin (2017). Enforcement of developmental lineage specificity by transcription factor Oct1. eLife, 6, (Read full publication)
    14. Almomen A, Jarboe EA, Dodson MK, Peterson CM, Owen SC, Janát-Amsbury M (2016). Imiquimod Induces Apoptosis in Human Endometrial Cancer Cells In vitro and Prevents Tumor Progression In vivo. Pharmaceutical research, 33(9), 2209-17. (Read full publication)
    15. Cho S, Park H, Jarboe EA, Peterson CM, Bae YH, Janát-Amsbury M (2015). Design and Characterization of Bioengineered Cancer-Like Stem Cells. PloS one, 10(10), e0141172. (Read full publication)
    16. Fata CR, Seeley EH, Desouki MM, Du L, Gwin K, Hanley KZ, Hecht JL, Jarboe EA, Liang SX, Parkash V, Quick CM, Zheng W, Shyr Y, Caprioli RM, Fadare (2015). Are clear cell carcinomas of the ovary and endometrium phenotypically identical? A proteomic analysis. Human pathology, 46(10), 1427-36. (Read full publication)
    17. Yang CH, Almomen A, Wee YS, Jarboe EA, Peterson CM, Janát-Amsbury M (2015). An estrogen-induced endometrial hyperplasia mouse model recapitulating human disease progression and genetic aberrations. Cancer medicine, 4(7), 1039-50. (Read full publication)
    18. Almomen A, Cho S, Yang CH, Li Z, Jarboe EA, Peterson CM, Huh KM, Janát-Amsbury M (2015). Thermosensitive progesterone hydrogel: a safe and effective new formulation for vaginal application. Pharmaceutical research, 32(7), 2266-79. (Read full publication)
    19. Fadare O, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Zheng W, Parkash V, Hecht J (2014). Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility. (cited over 100 times). The American journal of surgical pathology, 38(2), 189-96. (Read full publication)
    20. Jarboe EA, Hirschowitz SL, Geiersbach KB, Wallander ML, Tripp SR, Layfield L (2014). Juvenile granulosa cell tumors: immunoreactivity for CD99 and Fli-1 and EWSR1 translocation status: a study of 11 cases. International journal of gynecological pathology, 33(1), 11-5. (Read full publication)
    21. Cho S, Sun Y, Jarboe EA, Soisson AP, Dodson MK, Gaffney DK, Peterson CM, Janát-Amsbury M (2013). Mucoadhesive hybrid gel improves intraperitoneal platinum delivery. International journal of pharmaceutics, 458(1), 148-55. (Read full publication)
    22. Cho S, Sun Y, Soisson AP, Dodson MK, Peterson CM, Jarboe EA, Kennedy AM, Janát-Amsbury M (2013). Characterization and evaluation of pre-clinical suitability of a syngeneic orthotopic mouse ovarian cancer model. Anticancer research, 33(4), 1317-24. (Read full publication)
    23. Furtado LV, Paxton CN, Jama MA, Tripp SR, Wilson AR, Lyon E, Jarboe EA, Thaker HM, Geiersbach K (2013). Diagnostic utility of microsatellite genotyping for molar pregnancy testing. Archives of pathology & laboratory medicine, 137(1), 55-63. (Read full publication)

    Review

    1. Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney (2020). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT?. Gynecologic oncology, 156(1), 243-250. (Read full publication)
    2. Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum C (2008). Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology, 53(2), 127-38. (Read full publication)
    3. Salah HT, Stivers NS, Jarboe EA, Dodson MK, Ward M (2021). Extraskeletal Myxoid Chondrosarcoma of the Vulva Confirmed by EWSR1 FISH: A Case Report and Review of the Literature. International journal of gynecological pathology, 40(5), 470-476. (Read full publication)
    4. Longacre TA, Broaddus R, Chuang LT, Cohen MB, Jarboe EA, Mutter GL, Otis CN, Zaino RJ, Members of the Cancer Biomarker Reporting Committee, College of American Pathologist (2017). Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium. Archives of pathology & laboratory medicine, 141(11), 1508-1512. (Read full publication)
    5. Williams NL, Werner TL, Jarboe EA, Gaffney D (2015). Adenocarcinoma of the cervix: should we treat it differently?. Current oncology reports, 17(4), 17. (Read full publication)
    6. Shaaban AM, Rezvani M, Elsayes KM, Baskin H Jr, Mourad A, Foster BR, Jarboe EA, Menias C (2014). Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features. (cited over 200 times). Radiographics, 34(3), 777-801. (Read full publication)

    Book Chapter

    1. Jarboe EA, Folkins A, Callahan MJ, Crum C (2008). Pathology of BRCA-Associated Ovarian Cancers, Including Occult Cancers. 29-44.